Catalent, Inc. (CTLT)
NYSE: CTLT · IEX Real-Time Price · USD
55.92
+0.12 (0.22%)
At close: Apr 26, 2024, 4:00 PM
55.68
-0.24 (-0.43%)
After-hours: Apr 26, 2024, 7:47 PM EDT
Catalent Revenue
Catalent had revenue of $4.10B in the twelve months ending December 31, 2023, down -13.38% year-over-year. Revenue in the quarter ending December 31, 2023 was $1.02B, a -10.88% decrease year-over-year. In the fiscal year ending June 30, 2023, Catalent had annual revenue of $4.26B, a decrease of -11.22%.
Revenue (ttm)
$4.10B
Revenue Growth
-13.38%
P/S Ratio
2.47
Revenue / Employee
$230,225
Employees
17,800
Market Cap
10.12B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 4.26B | -539.00M | -11.22% |
Jun 30, 2022 | 4.80B | 804.00M | 20.11% |
Jun 30, 2021 | 4.00B | 904.00M | 29.22% |
Jun 30, 2020 | 3.09B | 576.00M | 22.88% |
Jun 30, 2019 | 2.52B | 54.60M | 2.22% |
Jun 30, 2018 | 2.46B | 388.00M | 18.70% |
Jun 30, 2017 | 2.08B | 227.30M | 12.30% |
Jun 30, 2016 | 1.85B | 17.30M | 0.94% |
Jun 30, 2015 | 1.83B | 3.10M | 0.17% |
Jun 30, 2014 | 1.83B | 27.40M | 1.52% |
Jun 30, 2013 | 1.80B | 105.50M | 6.22% |
Jun 30, 2012 | 1.69B | 163.00M | 10.64% |
Jun 30, 2011 | 1.53B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Tenet Healthcare | 20.56B |
Universal Health Services | 14.28B |
Henry Schein | 12.34B |
Solventum | 8.20B |
Smith & Nephew | 5.55B |
Teleflex | 2.97B |
Bruker | 2.96B |
United Therapeutics | 2.33B |
CTLT News
- 9 days ago - Robbins LLP Reminds Stockholders it is Investigating the Acquisition of Catalent, Inc. (CTLT) - Business Wire
- 19 days ago - Novo Nordisk parent refiles US application on Catalent deal - Reuters
- 24 days ago - Invenra Inc. Announces a Strategic Collaboration with Catalent to Co-Discover Novel Bispecific ADCs - Business Wire
- 6 weeks ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT - PRNewsWire
- 7 weeks ago - Novo Nordisk expects Catalent deal to close later this year - Reuters
- 7 weeks ago - Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment - Business Wire
- 2 months ago - CATALENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalent, Inc. - CTLT - Business Wire
- 2 months ago - Wegovy packing supplier Catalent lays off 300 workers - Reuters